Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Joao Gorgulho, Christoph Roderburg, Felix Heymann, Maximilian Schulze‐Hagen, Fabian Beier, Mihael Vucur, Jakob N. Kather, Narmin Ghaffari Laleh, Frank Tacke, Tim H. Brümmendorf, Tom Luedde, Sven H. Loosen

Journal title: International Journal of Cancer

Journal publisher: John Wiley & Sons Inc.

Published year: 2021

DOI identifier: 10.1002/ijc.33610

ISSN: 0020-7136